A new research paper was published in Oncotarget's Volume 15 on June 13, 2024, entitled, "Assessment of serum tumor markers CEA, CA-125, and CA19-9 as adjuncts in non-small cell lung cancer management ...
Serum tumor markers (STMs), including alpha-fetoprotein (AFP) and human chorionic gonadotropin (hCG), are currently used in management of patients with germ cell tumors (GCTs). STMs in a substantial ...
Breast cancer remains a predominant global health challenge for women, with late-stage diagnosis being a key contributor to its high mortality. This is particularly pronounced in low-resource settings ...
However, tumor marker tests aren’t the only tools they’ll use in cancer care. Other testing techniques will help provide a more comprehensive look at your type of cancer. Regular cells may produce ...
Validating Risk Prediction Models for Multiple Primaries and Competing Cancer Outcomes in Families With Li-Fraumeni Syndrome Using Clinically Ascertained Data Using a training/validation study design, ...
Tumor marker blood tests may help inform various aspects of cancer care, including diagnosis, staging, treatment planning, and outlook. However, they’re often not the only diagnostic tests used. If ...
A new study published in the journal of Biomarkers in Medicine showed that the development of new-onset cancer is ...
Please provide your email address to receive an email when new articles are posted on . Vitamin E significantly reduced serum ALT and AST in patients with MASLD. It also significantly increased MASH ...
This work was supported by the National Natural Science Foundation of China (Grant No. 82373113, XJ), Shenyang Breast Cancer ...
Monitoring gene activity in the brain just got a major upgrade. Rice University bioengineers have developed a novel serum marker system that can be “erased” in the bloodstream, enabling researchers to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback